These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29481941)

  • 21. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
    Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
    Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
    Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
    J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
    Chan YC; Cheng SW; Ting AC; Cheung GC
    J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Implantation Defects on Intermediate Outcome of Supera Stent for Popliteal Artery Stenosis.
    San Norberto EM; Fuente R; Flota CM; Taylor JH; Vaquero C
    Ann Vasc Surg; 2017 May; 41():186-195. PubMed ID: 28238922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty.
    Bosiers M; Scheinert D; Hendriks JM; Wissgott C; Peeters P; Zeller T; Brodmann M; Staffa R;
    J Vasc Surg; 2016 Jul; 64(1):109-16. PubMed ID: 27139789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. French multicenter experience with the GORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries.
    Sibé M; Kaladji A; Boirat C; Cardon A; Chaufour X; Bossavy JP; Saint-Lebes B
    J Vasc Surg; 2017 May; 65(5):1329-1335. PubMed ID: 28222987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts.
    Joviliano EE; Piccinato CE; Dellalibera-Joviliano R; Moriya T; Évora PR
    Ann Vasc Surg; 2011 Aug; 25(6):846-55. PubMed ID: 21620656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
    J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B; Akturk S; Akturk U; Tdjani M
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification and clinical impact of restenosis after femoropopliteal stenting.
    Tosaka A; Soga Y; Iida O; Ishihara T; Hirano K; Suzuki K; Yokoi H; Nanto S; Nobuyoshi M
    J Am Coll Cardiol; 2012 Jan; 59(1):16-23. PubMed ID: 22192663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.